Nuclear Medicine Market
Nuclear Medicine Market - Global Industry Assessment & Forecast
#
Pages:
145
2022
Sep - 2022
VMR-1847
Segments Covered
By
Type Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes
-
By
Applications Diagnostic Applications, Procedural Volume Assessment, Diagnostic Procedures, Therapeutic Procedures
-
By
Procedural Volume Assessment Diagnostic Procedures, Therapeutic Procedures
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 7.88 Billion |
 Revenue 2030:
|
USD 20.37 Billion |
 Revenue CAGR
(2023 - 2030): |
12.60% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Nuclear Medicine Market by Type by Applications by Procedural Volume Assessment by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Nuclear Medicine supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Nuclear Medicine market size at regional and country level
- Key industry players and their market share and Nuclear Medicine market-specific sales/revenue
- Understanding of the Nuclear Medicine supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Nuclear Medicine market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Nuclear Medicine market.
Vantage Market
Research | 15-Sep-2022
FAQ
Frequently Asked Question
What is the global demand for Nuclear Medicine in terms of revenue?
-
The global Nuclear Medicine valued at USD 7.88 Billion in 2022 and is expected to reach USD 20.37 Billion in 2030 growing at a CAGR of 12.60%.
Which are the prominent players in the market?
-
The prominent players in the market are Curium, Bracco Imaging S.P.A., Pharmalogic, Eczacibaşi-Monrol Nuclear Products, Cardinal Health, NTP Radioisotopes SOC LTD. (A Subsidiary of South African Nuclear Energy Corporation), GE Healthcare, Nordion Inc. (A Sotera Health Company), Advanced Accelerator Applications (AAA) (A part of Novartis), Northstar Medical Radioisotopes LLC, Eckert & Ziegler, Joint Stock Company Isotope (JSC Isotope), Bayer AG, Siemens Healthineers, Jubilant Draximage Inc. (A Subsidiary of Jubilant Pharma), Lantheus Medical Imaging Inc., Global Medical Solutions, Shine Medical Technologies, Isotopia Molecular Imaging Ltd., Sinotau Pharmaceutical Group, Institute of Isotopes Co. Ltd., China Isotope & Radiation Corporation, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Cyclopharm, IRE Elit.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Nuclear Medicine include
- Increasing incidence and prevalence of target conditions
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Nuclear Medicine in 2022.
